Literature DB >> 7901230

Drug-induced parotitis.

D F Thompson1.   

Abstract

Drug-induced parotitis is a relatively uncommon adverse drug reaction. Most of the data on drug-induced parotitis consist of isolated case reports with few attempts at rechallenge to confirm the aetiology. Phenylbutazone and oxyphenbutazone have a significant number of reports suggesting that these drugs may be implicated in causing parotitis. Antipsychotics, particularly thioridazine, have been associated with parotitis. Most of these reports relate the anticholinergic oral drying as a predisposing factor in the development of a parotid gland infection. There is inadequate literature on the histamine (H2) receptor blockers, interferon-alpha, doxycycline, trimipramine, nifedipine, methyldopa, nitrofurantoin, nicardipine, isoproterenol or ritodrine to link them as aetiological agents in the development of parotitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901230     DOI: 10.1111/j.1365-2710.1993.tb00584.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  2 in total

1.  Neonatal inflammatory submandibular sialadenitis associated with prenatal methyldopa exposure.

Authors:  Mehmet Nevzat Cizmeci; Mehmet Kenan Kanburoglu; Ahmet Zulfikar Akelma; Dilara Dilsad Malli; Kayihan Akin; Mustafa Mansur Tatli
Journal:  J Pediatr Pharmacol Ther       Date:  2014-04

2.  Concurrence of Stevens-Johnson Syndrome and Bilateral Parotitis after Minocycline Therapy.

Authors:  Jimi Yoon; Seung Hun Lee; Tae-Heung Kim; Deok-Jin Choi; Jin-Pyeong Kim; Tae-Jin Yoon
Journal:  Case Rep Dermatol       Date:  2010-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.